Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study-Reference-Cited by-同舟云学术

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Published:2016-11 Issue:11 Volume:17 Page:1533-1542
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Reijneveld Jaap C,Taphoorn Martin J B,Coens Corneel,Bromberg Jacoline E C,Mason Warren P,Hoang-Xuan Khê,Ryan Gail,Hassel Mohamed Ben,Enting Roelien H,Brandes Alba A,Wick Antje,Chinot Olivier,Reni Michele,Kantor Guy,Thiessen Brian,Klein Martin,Verger Eugenie,Borchers Christian,Hau Peter,Back Michael,Smits Anja,Golfinopoulos Vassilis,Gorlia Thierry,Bottomley Andrew,Stupp Roger,Baumert Brigitta G

Funder

National Cancer Institute grants

Medical Research Council Clinical Trials Unit at University College London from Cancer Research UK

Canadian Cancer Society Research Institute

National Health and Medical Research Council project grant

Publisher

Elsevier BV

Subject

Oncology

Reference42 articles.

1. Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force;Soffietti;Eur J Neurol,2010

2. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial;van den Bent;Lancet,2005